Tryptanthrin (Synonyms: トリプタントリン)

Name: Tryptanthrin
Brand: MedChemExpress
SKU: HY-N6607
Rating: 5.0 (8 reviews)

製品番号: HY-N6607 純度: 99.83%: Data Sheet SDS COA 取扱説明書
FAQs
Technical Support

Tryptanthrin is an indole quinazoline that could be an alkaloid from indigo-bearing plants. Tryptanthrin is a potent and orally active cellular Leukotriene (LT) biosynthesis inhibitor. Tryptanthrin has anticancer activity. Tryptanthrin suppresses the expression levels of NOS1, COX-2, and NF-κB and regulates the expression levels of IL-2, IL-10, and TNF-α.

商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。

Tryptanthrin 構造式

CAS 番号 : 13220-57-0

容量	価格（税別）	在庫状況	数量

>無料サンプル (0.1 - 0.2 mg)		今すぐ申し込む
Solid + Solvent (Highly Recommended)
10 mM * 1 mL in DMSO ready for reconstitution	USD 55	在庫あり	Estimated Time of Arrival: December 31
Solution
10 mM * 1 mL in DMSO	USD 55	在庫あり	Estimated Time of Arrival: December 31
Solid
5 mg	$50	在庫あり	Estimated Time of Arrival: December 31
10 mg	$85	在庫あり	Estimated Time of Arrival: December 31
25 mg	$160	在庫あり	Estimated Time of Arrival: December 31
50 mg	$255	在庫あり	Estimated Time of Arrival: December 31
100 mg	$335	在庫あり	Estimated Time of Arrival: December 31
200 mg		お問い合わせ
500 mg		お問い合わせ

or バルクお問い合わせ

* アイテムを追加する前、数量をご選択ください

This product is a controlled substance and not for sale in your territory.

カスタマーレビュー

Based on 8 publication(s) in Google Scholar

Other Forms of Tryptanthrin:

Tryptanthrin (Standard) 在庫あり

顧客検証

Leukotriene Receptor アイソフォーム固有の製品をすべて表示:

すべてのアイソフォームを表示

LTB₄ LTC₄/CysLT₂ LTD₄/CysLT₁ LTE₄

NO Synthase アイソフォーム固有の製品をすべて表示:

すべてのアイソフォームを表示

nNOS iNOS eNOS

NF-κB アイソフォーム固有の製品をすべて表示:

すべてのアイソフォームを表示

NF-κB NF-κB1/p50 RelA/p65 RelB c-Rel

COX アイソフォーム固有の製品をすべて表示:

すべてのアイソフォームを表示

COX COX-1 COX-2 COX-3

TNF Receptor アイソフォーム固有の製品をすべて表示:

すべてのアイソフォームを表示

TNFRSF1A/CD120a TNFRSF3/CD18 TNFRSF4 TNFRSF5/CD40 TNFRSF6/Fas/CD95 TNFRSF7/CD27 TNFRSF8/CD30 TNFRSF9/4-1BB/CD137 TNFRSF10B/DR5/CD262 TNFRSF12A/TWEAK TNFRSF16/NGF Receptor/CD271 TNFRSF18/GITR/CD357

Interleukin Related アイソフォーム固有の製品をすべて表示:

すべてのアイソフォームを表示

IL-1 IL-2 IL-3 IL-4 IL-5 IL-6 IL-8 IL-10 IL-12 IL-13 IL-15 IL-17 IL-23 IL-7 IL-33 IL-22 IL-18

生物活性
純度とドキュメンテーション
参考文献
カスタマーレビュー

製品説明

IC₅₀ & Target^[1]

IL-2

nNOS

IL-6

IL-10

IL-12

Cellular Effect

Cell Line	Type	Value	Description	References
A-431	IC₅₀	9 μM Compound: 47	Anticancer activity against human A-431 cells assessed as reduction of cell viability incubated for 48 hrs by MTT assay Anticancer activity against human A-431 cells assessed as reduction of cell viability incubated for 48 hrs by MTT assay	[PMID: 36375335]
A498	GI₅₀	0.95 μM Compound: 1 (Tryptanthrine)	Tested for in vitro cytotoxic activity against renal A498 human cancer cell lines Tested for in vitro cytotoxic activity against renal A498 human cancer cell lines	[PMID: 12161121]
A498	GI₅₀	0.95 μM Compound: 1; Try	Growth inhibition of human A498 cells assessed as reduction in cell viability Growth inhibition of human A498 cells assessed as reduction in cell viability	[PMID: 38665827]
A498	GI₅₀	0.95 μM Compound: 47	Growth inhibition of human A498 cells by SRB method Growth inhibition of human A498 cells by SRB method	[PMID: 36375335]
A549	IC₅₀	>100 μM Compound: 1; Try	Antiproliferative activity against human A549 cells assessed as inhibition of cell viability Antiproliferative activity against human A549 cells assessed as inhibition of cell viability	[PMID: 38665827]
A549	IC₅₀	>150 μM Compound: 1; Try	Antiproliferative activity against human A549 cells assessed as cell growth inhibition Antiproliferative activity against human A549 cells assessed as cell growth inhibition	[PMID: 38665827]
A549	IC₅₀	74.71 μM Compound: 1; Try	Antiproliferative activity against human A549 cells Antiproliferative activity against human A549 cells	[PMID: 38665827]
A549	IC₅₀	74.71 μM Compound: 1; Try	Antiproliferative activity against human A549 cells measured after 48 hrs by MTT assay Antiproliferative activity against human A549 cells measured after 48 hrs by MTT assay	[PMID: 38665827]
A549	IC₅₀	8.25 μM Compound: 1; Try	Antiproliferative activity against human A549 cells incubated by 48 hrs by MTT assay Antiproliferative activity against human A549 cells incubated by 48 hrs by MTT assay	[PMID: 38665827]
A549/CDDP	IC₅₀	>100 μM Compound: 1; Try	Antiproliferative activity against human A549/DDP cells assessed as inhibition of cell viability Antiproliferative activity against human A549/DDP cells assessed as inhibition of cell viability	[PMID: 38665827]
Bel-7402	IC₅₀	41.29 μM Compound: 1; Try	Antiproliferative activity against human Bel-7402 cells measured after 48 hrs by MTT assay Antiproliferative activity against human Bel-7402 cells measured after 48 hrs by MTT assay	[PMID: 38665827]
CCRF-CEM	GI₅₀	14.47 μM Compound: Tryptanthrin	Antiproliferative activity against human CCRF-CEM cells assessed as reduction in cell viability after 72 hrs by eosin exclusion dye based light microscopic method Antiproliferative activity against human CCRF-CEM cells assessed as reduction in cell viability after 72 hrs by eosin exclusion dye based light microscopic method	[PMID: 32712536]
CCRF-CEM	IC₅₀	44.36 μM Compound: Tryptanthrin	Antiproliferative activity against human CCRF-CEM cells assessed as reduction in cell viability after 72 hrs by eosin exclusion dye based light microscopic method Antiproliferative activity against human CCRF-CEM cells assessed as reduction in cell viability after 72 hrs by eosin exclusion dye based light microscopic method	[PMID: 32712536]
DU-145	GI₅₀	0.4 μM Compound: 1 (Tryptanthrine)	Tested for in vitro cytotoxic activity against prostate DU145 human cancer cell lines Tested for in vitro cytotoxic activity against prostate DU145 human cancer cell lines	[PMID: 12161121]
DU-145	GI₅₀	0.4 μM Compound: 1; Try	Growth inhibition of human DU-145 cells assessed as reduction in cell viability Growth inhibition of human DU-145 cells assessed as reduction in cell viability	[PMID: 38665827]
DU-145	GI₅₀	0.4 μM Compound: 47	Growth inhibition of human DU-145 cells by sulforhodamine B assay Growth inhibition of human DU-145 cells by sulforhodamine B assay	[PMID: 36375335]
DU-145	IC₅₀	6.22 μM Compound: 1a	Cytotoxicity against human DU145 cells after 72 hrs by MTT assay Cytotoxicity against human DU145 cells after 72 hrs by MTT assay	[PMID: 22819942]
HCT-116	IC₅₀	17.49 μM Compound: 1; Try	Antiproliferative activity against human HCT-116 cells measured after 48 hrs by MTT assay Antiproliferative activity against human HCT-116 cells measured after 48 hrs by MTT assay	[PMID: 38665827]
HCT-15	IC₅₀	8.49 μM Compound: 1a	Cytotoxicity against human HCT15 cells after 72 hrs by MTT assay Cytotoxicity against human HCT15 cells after 72 hrs by MTT assay	[PMID: 22819942]
HEK293	IC₅₀	0.0537 μM Compound: 5a, Tryptanthrin	Inhibition of human IDO1 expressed in HEK293 cells assessed as kynurenine release after 5 hrs by spectrophotometry Inhibition of human IDO1 expressed in HEK293 cells assessed as kynurenine release after 5 hrs by spectrophotometry	[PMID: 24099220]
HEK293	IC₅₀	0.14 μM Compound: 5a	Inhibition of TDO (unknown origin) expressed in HEK293 cells using L-Trp as substrate after 8 hrs Inhibition of TDO (unknown origin) expressed in HEK293 cells using L-Trp as substrate after 8 hrs	[PMID: 30321802]
HEK293	IC₅₀	4.11 μM Compound: 1a	Cytotoxicity against human HEK293 cells after 72 hrs by MTT assay Cytotoxicity against human HEK293 cells after 72 hrs by MTT assay	[PMID: 22819942]
HeLa	IC₅₀	>150 μM Compound: 1; Try	Antiproliferative activity against human HeLa cells assessed as cell growth inhibition Antiproliferative activity against human HeLa cells assessed as cell growth inhibition	[PMID: 38665827]
HepG2	IC₅₀	305.4 ng/mL Compound: tryptanthrin	Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay	[PMID: 25654185]
HepG2	IC₅₀	9.51 μM Compound: 1; Try	Antiproliferative activity against human HepG2 cells incubated by 48 hrs by MTT assay Antiproliferative activity against human HepG2 cells incubated by 48 hrs by MTT assay	[PMID: 38665827]
HepG2	IC₅₀	90.14 μM Compound: 1; Try	Antiproliferative activity against human HepG2 cells assessed as inhibition of cell growth Antiproliferative activity against human HepG2 cells assessed as inhibition of cell growth	[PMID: 38665827]
HepG2	IC₅₀	90.14 μM Compound: 1; Try	Antiproliferative activity against human HepG2 cells measured after 48 hrs by MTT assay Antiproliferative activity against human HepG2 cells measured after 48 hrs by MTT assay	[PMID: 38665827]
HL-60	IC₅₀	2 μM Compound: TBr; 1a	Antiproliferative activity against human HL60 cells after 48 hrs Antiproliferative activity against human HL60 cells after 48 hrs	[PMID: 28720329]
HL-60	IC₅₀	5 μM Compound: TBr; 1a	Antiproliferative activity against human HL60 cells after 24 hrs Antiproliferative activity against human HL60 cells after 24 hrs	[PMID: 28720329]
Huh-7	CC₅₀	>10 μM Compound: GNF-Pf-2691	NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7) NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)	[PMID: 18579783]
K562	IC₅₀	12.04 μM Compound: 1; Try	Antiproliferative activity against human K562 cells incubated by 48 hrs by MTT assay Antiproliferative activity against human K562 cells incubated by 48 hrs by MTT assay	[PMID: 38665827]
K562	IC₅₀	15 μM Compound: TBr; 1a	Antiproliferative activity against human K562 cells after 24 hrs Antiproliferative activity against human K562 cells after 24 hrs	[PMID: 28720329]
K562	IC₅₀	5 μM Compound: TBr; 1a	Antiproliferative activity against human K562 cells after 48 hrs Antiproliferative activity against human K562 cells after 48 hrs	[PMID: 28720329]
K562	IC₅₀	6.3 μg/mL Compound: 47	Cytotoxicity against human K562 cells assessed reduction in cell growth incubated for 48 hrs by MTT assay Cytotoxicity against human K562 cells assessed reduction in cell growth incubated for 48 hrs by MTT assay	[PMID: 36375335]
K562	IC₅₀	8.8 μg/mL Compound: TBr; 1a	Antiproliferative activity against human K562 cells after 48 hrs by MTT staining-based method Antiproliferative activity against human K562 cells after 48 hrs by MTT staining-based method	[PMID: 28720329]
L02	IC₅₀	>100 μM Compound: 1; Try	Antiproliferative activity against human HL7702 cells assessed as inhibition of cell viability Antiproliferative activity against human HL7702 cells assessed as inhibition of cell viability	[PMID: 38665827]
L02	IC₅₀	90.12 μM Compound: 1; Try	Antiproliferative activity against human HL7702 cells assessed as inhibition of cell growth Antiproliferative activity against human HL7702 cells assessed as inhibition of cell growth	[PMID: 38665827]
L02	IC₅₀	90.12 μM Compound: 1; Try	Antiproliferative activity against human HL7702 cells measured after 48 hrs by MTT assay Antiproliferative activity against human HL7702 cells measured after 48 hrs by MTT assay	[PMID: 38665827]
M14	GI₅₀	15 μM Compound: 1 (Tryptanthrine)	Tested for in vitro cytotoxic activity against melanoma M14 human cancer cell lines Tested for in vitro cytotoxic activity against melanoma M14 human cancer cell lines	[PMID: 12161121]
M14	GI₅₀	15 μM Compound: 1; Try	Growth inhibition of human M14 cells assessed as reduction in cell viability Growth inhibition of human M14 cells assessed as reduction in cell viability	[PMID: 38665827]
M14	GI₅₀	15 μM Compound: 47	Growth inhibition of human M14 cells Growth inhibition of human M14 cells	[PMID: 36375335]
MC3T3-E1	IC₅₀	>100 μM Compound: 1; Try	Antiproliferative activity against mouse MC3T3-E1 cells Antiproliferative activity against mouse MC3T3-E1 cells	[PMID: 38665827]
MCF7	IC₅₀	0.58 μM Compound: TBr; 1a	Cytotoxicity against human wild-type MCF7 cells after 72 hrs Cytotoxicity against human wild-type MCF7 cells after 72 hrs	[PMID: 28720329]
MCF7	IC₅₀	11.1 μM Compound: 7	Cytotoxicity against human MCF7 cells Cytotoxicity against human MCF7 cells	[PMID: 18507473]
MCF7	IC₅₀	94.2 μM Compound: 1; Try	Antiproliferative activity against human MCF7 cells Antiproliferative activity against human MCF7 cells	[PMID: 38665827]
MDA-MB-231	IC₅₀	>100 μM Compound: 1; Try	Antiproliferative activity against human MDA-MB-231 cells measured after 48 hrs by MTT assay Antiproliferative activity against human MDA-MB-231 cells measured after 48 hrs by MTT assay	[PMID: 38665827]
MGC-803	IC₅₀	70.19 μM Compound: 1; Try	Antiproliferative activity against human MGC-803 cells measured after 48 hrs by MTT assay Antiproliferative activity against human MGC-803 cells measured after 48 hrs by MTT assay	[PMID: 38665827]
MOLT-4	IC₅₀	10 μM Compound: TBr; 1a	Antiproliferative activity against human MOLT4 cells after 24 hrs Antiproliferative activity against human MOLT4 cells after 24 hrs	[PMID: 28720329]
MOLT-4	IC₅₀	8 μM Compound: TBr; 1a	Antiproliferative activity against human MOLT4 cells after 48 hrs Antiproliferative activity against human MOLT4 cells after 48 hrs	[PMID: 28720329]
NCI/ADR-RES	GI₅₀	30 μM Compound: 1 (Tryptanthrine)	Tested for in vitro cytotoxic activity against breast MCF-7/ADR human cancer cell lines Tested for in vitro cytotoxic activity against breast MCF-7/ADR human cancer cell lines	[PMID: 12161121]
NCI/ADR-RES	GI₅₀	30 μM Compound: 1; Try	Growth inhibition of human MCF7ADR cells assessed as reduction in cell viability Growth inhibition of human MCF7ADR cells assessed as reduction in cell viability	[PMID: 38665827]
NCI/ADR-RES	GI₅₀	30 μM Compound: 47	Growth inhibition of human MCF7ADR cells Growth inhibition of human MCF7ADR cells	[PMID: 36375335]
NCI/ADR-RES	IC₅₀	0.03 μM Compound: TBr; 1a	Cytotoxicity against human MCF7/ADR cells after 72 hrs Cytotoxicity against human MCF7/ADR cells after 72 hrs	[PMID: 28720329]
NCI/ADR-RES	IC₅₀	96.4 μM Compound: 1; Try	Antiproliferative activity against human MCF7ADR cells Antiproliferative activity against human MCF7ADR cells	[PMID: 38665827]
NCI-H460	IC₅₀	9 μM Compound: 7	Cytotoxicity against human NCI-H460 cells Cytotoxicity against human NCI-H460 cells	[PMID: 18507473]
NCI-H522	GI₅₀	15 μM Compound: 1 (Tryptanthrine)	Tested for in vitro cytotoxic activity against lung H522 human cancer cell lines Tested for in vitro cytotoxic activity against lung H522 human cancer cell lines	[PMID: 12161121]
NCI-H522	GI₅₀	15 μM Compound: 1; Try	Growth inhibition of human NCI-H522 cells assessed as reduction in cell viability Growth inhibition of human NCI-H522 cells assessed as reduction in cell viability	[PMID: 38665827]
NCI-H522	GI₅₀	15 μM Compound: 47	Growth inhibition of human NCI-H522 cells Growth inhibition of human NCI-H522 cells	[PMID: 36375335]
PC-3	IC₅₀	14.52 μM Compound: 1; Try	Antiproliferative activity against human PC-3 cells incubated by 48 hrs by MTT assay Antiproliferative activity against human PC-3 cells incubated by 48 hrs by MTT assay	[PMID: 38665827]
SF-268	IC₅₀	24.4 μM Compound: 7	Cytotoxicity against human SF268 cells Cytotoxicity against human SF268 cells	[PMID: 18507473]
SH-SY5Y	IC₅₀	22 μM Compound: 47	Cytotoxicity against human SH-SY5Y cells assessed as reduction in cell viability Cytotoxicity against human SH-SY5Y cells assessed as reduction in cell viability	[PMID: 36375335]
SK-N-DZ	IC₅₀	14 μM Compound: 47	Anticancer activity against human SK-N-DZ cells assessed as cell growth inhibition measured after 72 hrs by DAPI staining based analysis Anticancer activity against human SK-N-DZ cells assessed as cell growth inhibition measured after 72 hrs by DAPI staining based analysis	[PMID: 36375335]
SK-OV-3	GI₅₀	2.5 μM Compound: 1 (Tryptanthrine)	Tested for in vitro cytotoxic activity against ovarian SKOV3 human cancer cell lines Tested for in vitro cytotoxic activity against ovarian SKOV3 human cancer cell lines	[PMID: 12161121]
SK-OV-3	GI₅₀	2.5 μM Compound: 1; Try	Growth inhibition of human SK-OV-3 cells assessed as reduction in cell viability Growth inhibition of human SK-OV-3 cells assessed as reduction in cell viability	[PMID: 38665827]
SK-OV-3	GI₅₀	2.5 μM Compound: 47	Growth inhibition of human SK-OV-3 cells by sulforhodamine B assay Growth inhibition of human SK-OV-3 cells by sulforhodamine B assay	[PMID: 36375335]
SK-OV-3	IC₅₀	85.09 μM Compound: 1; Try	Antiproliferative activity against human SK-OV-3 cells assessed as inhibition of cell growth Antiproliferative activity against human SK-OV-3 cells assessed as inhibition of cell growth	[PMID: 38665827]
SW-620	GI₅₀	5 μM Compound: 1 (Tryptanthrine)	Tested for in vitro cytotoxic activity against colon SW620 human cancer cell lines Tested for in vitro cytotoxic activity against colon SW620 human cancer cell lines	[PMID: 12161121]
SW-620	GI₅₀	5 μM Compound: 1; Try	Growth inhibition of human SW620 cells assessed as reduction in cell viability Growth inhibition of human SW620 cells assessed as reduction in cell viability	[PMID: 38665827]
SW-620	GI₅₀	5 μM Compound: 47	Growth inhibition of human SW620 cells Growth inhibition of human SW620 cells	[PMID: 36375335]
T-24	IC₅₀	>150 μM Compound: 1; Try	Antiproliferative activity against human T24 cells assessed as inhibition of cell growth Antiproliferative activity against human T24 cells assessed as inhibition of cell growth	[PMID: 38665827]
T-24	IC₅₀	>150 μM Compound: 1; Try	Antiproliferative activity against human T24 cells measured after 48 hrs by MTT assay Antiproliferative activity against human T24 cells measured after 48 hrs by MTT assay	[PMID: 38665827]
T47D	IC₅₀	14.29 μM Compound: 1a	Cytotoxicity against human T47D cells after 72 hrs by MTT assay Cytotoxicity against human T47D cells after 72 hrs by MTT assay	[PMID: 22819942]
U-251	GI₅₀	100 μM Compound: 1 (Tryptanthrine)	Tested for in vitro cytotoxic activity against CNS U251 human cancer cell lines Tested for in vitro cytotoxic activity against CNS U251 human cancer cell lines	[PMID: 12161121]
U-251	GI₅₀	100 μM Compound: 1; Try	Growth inhibition of human U-251 cells assessed as reduction in cell viability Growth inhibition of human U-251 cells assessed as reduction in cell viability	[PMID: 38665827]
U-251	GI₅₀	100 μM Compound: 47	Growth inhibition of human U-251 cells Growth inhibition of human U-251 cells	[PMID: 36375335]
U-87MG ATCC	IC₅₀	0.194 μM Compound: 5a	Inhibition of TDO in human U87 MG cells using L-Trp as substrate after 8 hrs Inhibition of TDO in human U87 MG cells using L-Trp as substrate after 8 hrs	[PMID: 30321802]
U-87MG ATCC	IC₅₀	5 μM Compound: 5a	Inhibition of recombinant human IDO2 expressed in human U87MG cells assessed as reduction in kynurenine formation using L-tryptophan as substrate after 6 hrs by spectrophotometry Inhibition of recombinant human IDO2 expressed in human U87MG cells assessed as reduction in kynurenine formation using L-tryptophan as substrate after 6 hrs by spectrophotometry	[PMID: 27475108]
U-937	IC₅₀	3.1 μg/mL Compound: 47	Cytotoxicity against human U-937 cells assessed reduction in cell growth incubated for 48 hrs by MTT assay Cytotoxicity against human U-937 cells assessed reduction in cell growth incubated for 48 hrs by MTT assay	[PMID: 36375335]
Vero	IC₅₀	>100 μg/mL Compound: 2	Cytotoxicity against African green monkey Vero cells by CellTiter 96 aqueous nonradioactive cell proliferation assay Cytotoxicity against African green monkey Vero cells by CellTiter 96 aqueous nonradioactive cell proliferation assay	[PMID: 30295480]
Vero	IC₅₀	>8 μg/mL Compound: 1a, Tryptanthrin	Cytotoxicity against african green monkey Vero cells Cytotoxicity against african green monkey Vero cells	[PMID: 23360475]
WEHI3B	IC₅₀	1.5 μM Compound: 1; Try	Antiproliferative activity against mouse WEHI3B cells assessed as inhibition of cell growth measured after 48 hrs Antiproliferative activity against mouse WEHI3B cells assessed as inhibition of cell growth measured after 48 hrs	[PMID: 38665827]

体外実験

Tryptanthrin (0-60 μM; 24, 48 and 72 h) inhibits the proliferation and colony formation of MCF-7 cells^[1].
Tryptanthrin (6.25-25 μM; 48 h; MCF-7 cells) reverses EMT-associated E-cadherin, MMP-2 and Snail^[1].
Tryptanthrin (0-30 μM; 15 min; MCF-7 cells) reduces Leukotriene (LT)-formation in human neutrophils with an IC₅₀ value of 0.6 μM^[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Viability Assay^[1]

Cell Line:	MCF-7 cells
Concentration:	0-60 μM
Incubation Time:	24, 48 and 72 hours
Result:	Increased the inhibition rates of MCF-7 cells in a dose- and time- dependent manner.

Western Blot Analysis^[1]

Cell Line:	MCF-7 cells
Concentration:	6.25, 12.5, and 25 μM
Incubation Time:	48 hours
Result:	Increased the E-cadherin protein levels and markedly upregulated the protein expression levels of MMP-2 and Snail in MCF-7 cells induced by TGF-β1.

体内実験

Tryptanthrin (25-100 mg/kg; i.g.; daily, for 13 d; Female Bal b/c mice with 4T1 xenograft) inhibits tumor growth and regulates IL-2, IL-6, IL-10, IL-12 and TNF-α levels in tumor-bearing mice^[1].
Tryptanthrin (10 mg/kg; p.o.; male Wistar Han rats) inhibits LTB₄ formation in vivo^[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:	Female Bal b/c mice with 4T1 xenograft^[1]
Dosage:	25, 50, and 100 mg/kg
Administration:	Oral gavage; daily, for 13 days
Result:	Inhibited tumor growth in a dose-dependent manner.

Animal Model:	Male Wistar Han rats (220–230 g)^[2]
Dosage:	10 mg/kg
Administration:	Oral administration; once
Result:	Reduced LTB₄ pleural levels by 46%. Reduced PGE₂ levels (by 42%), exudate volume (by 80%) and the number of infiltrating cells (by 41%).

分子量

248.24

分子式

C₁₅H₈N₂O₂

CAS 番号

13220-57-0

Appearance

Solid

Color

Light yellow to yellow

SMILES

O=C1C2=CC=CC=C2N3C(C4=CC=CC=C4N=C13)=O

Structure Classification

Initial Source

輸送条件

Room temperature in continental US; may vary elsewhere.

保管条件

Powder	-20°C	3 years
	4°C	2 years
In solvent	-80°C	6 months
	-20°C	1 month

溶剤 & 溶解度

体外:

DMSO : 7.14 mg/mL (28.76 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

Preparing
Stock Solutions

Concentration Solvent Mass	1 mg	5 mg	10 mg

1 mM	4.0284 mL	20.1418 mL	40.2836 mL
5 mM	0.8057 mL	4.0284 mL	8.0567 mL
10 mM	0.4028 mL	2.0142 mL	4.0284 mL

View the Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.

Molarity Calculator
Dilution Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

一般には略語で表示されます：C₁V₁ = C₂V₂

濃度 _（開始）

体積 _（開始）

濃度 _（終了）

体積 _（終了）

体内:

Select the appropriate dissolution method based on your experimental animal and administration route.

For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

Protocol 1

Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: 0.71 mg/mL (2.86 mM); Suspended solution; Need ultrasonic

This protocol yields a suspended solution of 0.71 mg/mL. Suspended solution can be used for oral and intraperitoneal injection.
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (7.1 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Protocol 2

Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)
Solubility: 0.67 mg/mL (2.70 mM); Suspended solution; Need ultrasonic

This protocol yields a suspended solution of 0.67 mg/mL. Suspended solution can be used for oral and intraperitoneal injection.
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (6.7 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.

In Vivo Dissolution Calculator

Please enter the basic information of animal experiments:

Dosage

mg/kg

Animal weight
(per animal)

Dosing volume
(per animal)

μL

Number of animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.

Please enter your animal formula composition:

DMSO +

Tween-80 +

Saline

Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.

The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).

Calculation results:

Working solution concentration: mg/mL

Method for preparing stock solution: mg drug dissolved in μL DMSO (Stock solution concentration: mg/mL).

The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only. If necessary, please contact MedChemExpress (MCE).

Method for preparing in vivo working solution for animal experiments: Take μL DMSO stock solution, add μL . μL , mix evenly, next add μL Tween 80, mix evenly, then add μL Saline.

If the continuous dosing period exceeds half a month, please choose this protocol carefully.

Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.

純度とドキュメンテーション

純度: 99.83%

Select Batch:

データシート (284 KB) SDS (393 KB)

COA (255 KB) HNMR (247 KB) LCMS (87 KB)

取扱説明書 (2659 KB)

参考文献

[1]. Zeng Q, et, al. Tryptanthrin exerts anti-breast cancer effects both in vitro and in vivo through modulating the inflammatory tumor microenvironment. Acta Pharm. 2021 Jun 1;71(2):245-266. [Content Brief]

[2]. Pergola C, et, al. On the inhibition of 5-lipoxygenase product formation by tryptanthrin: mechanistic studies and efficacy in vivo. Br J Pharmacol. 2012 Feb;165(3):765-76. [Content Brief]

Complete Stock Solution Preparation Table

Optional Solvent	Concentration Solvent Mass	1 mg	5 mg	10 mg	25 mg

DMSO	1 mM	4.0284 mL	20.1418 mL	40.2836 mL	100.7090 mL
	5 mM	0.8057 mL	4.0284 mL	8.0567 mL	20.1418 mL
	10 mM	0.4028 mL	2.0142 mL	4.0284 mL	10.0709 mL
	15 mM	0.2686 mL	1.3428 mL	2.6856 mL	6.7139 mL
	20 mM	0.2014 mL	1.0071 mL	2.0142 mL	5.0354 mL
	25 mM	0.1611 mL	0.8057 mL	1.6113 mL	4.0284 mL

Tryptanthrin Related Classifications

Molarity Calculator
Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

質量		濃度		体積		分子量 *
	=		×		×

The dilution calculator equation

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

一般には略語で表示されます：C₁V₁ = C₂V₂

濃度 _（開始）	×	体積 _（開始）	=	濃度 _（終了）	×	体積 _（終了）
	×		=		×
C1		V1		C2		V2

Help & FAQs

Do most proteins show cross-species activity?
Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

日本の代理先をお選びくださいナミキ商事株式会社コスモ・バイオ株式会社重松貿易株式会社
製品名			カスタマ需要量 *
お名前 *			タイトル
メールアドレス *			電話番号 *
デパートメント			組纖名 *
市区町村			都道府県
国或いは地域 *
必ず会社名を記載ください。個人への返信は行いません。
備考

製品名			Lot #
お名前 *			メールアドレス *
電話番号 *			部門 *
組纖名 *			国或いは地域 *
備考

Tryptanthrin (Synonyms: トリプタントリン)

カスタマーレビュー

Other Forms of Tryptanthrin:

顧客検証

おすすめ

•関連スクリーニングライブラリ:

•関連小分子:

•関連タンパク質:

Leukotriene Receptor アイソフォーム固有の製品をすべて表示:

NO Synthase アイソフォーム固有の製品をすべて表示:

NF-κB アイソフォーム固有の製品をすべて表示:

COX アイソフォーム固有の製品をすべて表示:

TNF Receptor アイソフォーム固有の製品をすべて表示:

Interleukin Related アイソフォーム固有の製品をすべて表示:

生物活性

純度とドキュメンテーション

参考文献

カスタマーレビュー

Molarity Calculator

Dilution Calculator

Complete Stock Solution Preparation Table

Tryptanthrin Related Classifications

Molarity Calculator

Dilution Calculator

The molarity calculator equation

The dilution calculator equation

Keywords:

最近チェックした製品:

お名前
メール *

	Sorry, but the email address you supplied was invalid.

Tryptanthrin (Synonyms: トリプタントリン)

カスタマーレビュー

Other Forms of Tryptanthrin:

Tryptanthrin 関連抗体

顧客検証

おすすめ

•関連スクリーニングライブラリ:

•関連小分子:

•関連タンパク質:

Leukotriene Receptor アイソフォーム固有の製品をすべて表示:

NO Synthase アイソフォーム固有の製品をすべて表示:

NF-κB アイソフォーム固有の製品をすべて表示:

COX アイソフォーム固有の製品をすべて表示:

TNF Receptor アイソフォーム固有の製品をすべて表示:

Interleukin Related アイソフォーム固有の製品をすべて表示:

生物活性

純度とドキュメンテーション

参考文献

カスタマーレビュー

Tryptanthrin 関連抗体

Molarity Calculator

Dilution Calculator

Complete Stock Solution Preparation Table

Tryptanthrin Related Classifications

Molarity Calculator

Dilution Calculator

The molarity calculator equation

The dilution calculator equation

Keywords:

最近チェックした製品:

カスタマーレビュー

Request for HNMR Report

Request for HNMR Report